Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Duloxetine claimed for new indication

July 26, 1996

Positive safety profile reported on histamine H3 antagonist research

July 26, 1996

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

BMDB shows antinociceptive activity in mouse model

July 26, 1996

Trial results described for methylphenidate in head injury patients

July 19, 1996

Adenosine A1 antagonists described by German universities

July 19, 1996

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

Athena Neuroscience's BotB successfully completes phase II in cervical dystonia

July 19, 1996

GDNF vital for kidney and enteric nervous system development

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...